Insider trade

Director sold ~$126K of G shares in the open market

Traded Nov 12, 2025 · Filed Nov 14, 2025

Why it stands out

A board member of Genpact sold $126K of Genpact shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$100K–$500K

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$125,538

Shares × reported transaction price

Timing vs results

6 days after results of Nov 6, 2025, 85 days before results of Feb 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−1.2%	−1.9%	+0.7%
30 days	+5.5%	+1.3%	+4.2%
90 days	−19.1%	+1.4%	−20.5%
180 days	−34.4%	+10.5%	−44.9%

Past results only. Not a forecast.

Automatic sale11mo ago

Automatic sale11mo ago

11mo ago

Derivative exercise or conversion — not an open-market buy.